The alliance with Paris, France-based Iktos could be worth more than €1 billion in upfront, research funding, and milestone ...

Beyond the opportunities for start-ups, this change making direct primary care an eligible HSA expense represents a significant step in fighting chronic disease. This is because it allows the primary ...

Judges in the First US Circuit Court of Appeals in Boston have rejected an effort to overturn last month's injunction on the ...

A report in the Wall Street Journal, citing people familiar with the matter, suggested an announcement of a transaction could ...

Overall, it found that patients could lose up to a fifth of their body weight using the injectable GLP-1s, but put it back on at a rate of 0.8 kg a month after the treatment stopped, which means that ...

Jiangsu Hengrui Pharma has chalked up a first-in-class approval for retlirafusp alfa, a bifunctional drug that targets PD-L1 ...

The ISPOR Glasgow panel conveyed a constructive, forward looking mood: JCA can work – and work better over time – if ...

OpenAI has announced ChatGPT Health, which promises to bring users' medical records and health and wellness apps like Apple ...

Hutchmed is preparing to file for approval of a drug for the rare autoimmune disorder warm antibody autoimmune haemolytic ...

Eli Lilly is reported to be eyeing a $1 billion-plus takeover of Ventyx Biosciences that, if confirmed, suggests 2026 could ...

For pharmaceutical marketers, the pharmacy relationship is as powerful as it is underutilised. Rather than focusing outreach ...

Bayer's agrochemicals unit Monsanto has filed lawsuits in the US against the manufacturers of mRNA-based COVID-19 vaccines, ...